Study of PPP2R5C Gene Expression in Leukemia
Author Information
Author(s): Zheng Haitao, Chen Yu, Chen Shaohua, Niu Yuzhe, Yang Lijian, Li Bo, Lu Yuhong, Geng Suxia, Du Xin, Li Yangqiu
Primary Institution: Institute of Hematology, Medical College, Jinan University, Guangzhou, P.R. China
Hypothesis
The expression and distribution of the PPP2R5C gene in leukemia can provide insights into its role in cell proliferation and differentiation.
Conclusion
The study found that PPP2R5C is overexpressed in various types of leukemia, suggesting its involvement in the disease's progression.
Supporting Evidence
- PPP2R5C expression was significantly higher in AML, CML, T-ALL, and B-CLL compared to healthy controls.
- High expression of PPP2R5C was detected in the B-ALL group, but not significantly different from healthy controls.
- The expression level of PPP2R5C decreased significantly in the CML-CR group compared to de novo CML.
Takeaway
Researchers looked at a gene called PPP2R5C in leukemia patients and found that it is often more active in their blood than in healthy people, which might help us understand leukemia better.
Methodology
Real-time PCR and RT-PCR were used to analyze the expression levels of PPP2R5C in blood samples from leukemia patients and healthy individuals.
Limitations
The study did not include samples from patients in complete remission for all leukemia types, limiting the ability to compare expression levels across different disease states.
Participant Demographics
77 patients with de novo leukemia, 26 patients in complete remission, and 20 healthy individuals.
Statistical Information
P-Value
p = 0.0076 for AML, p < 0.0001 for CML, p = 0.0062 for T-ALL, p = 0.0417 for B-CLL
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website